Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application
Lupin Limited announced that the U.S. FDA has accepted the Biologics License Application (BLA) for its ...
Read more
Tag: Biosimilar
Seagen and Astellas Announce U.S. FDA Acceptance of Two Supplemental Biologics License Applications
- Priority Review Granted with Action Date of August 17 - - Australia and Canada Regulators ...
Read more